Dunhill Financial’s NeoGenomics NEO Stock Holding History

Dunhill Financial’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26	Hold	1	–	–	﹤0.01%	1578
2026 Q1	$13	Sell	1 -1	-50%	-$11	﹤0.01%	1811
2025 Q4	$21	Buy	+2	New	+$22	﹤0.01%	1898

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Dunhill Financial's NEO Position: Q2 2026 in Review

Dunhill Financial held its NeoGenomics (NEO) position steady in Q2 2026 at 1 share worth $26. The position accounts for ﹤0.01% of the portfolio, ranked #1578.

Dunhill Financial first reported a position in NEO in Q4 2025 and has held it in 3 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

Dunhill Financial held 1 share of NeoGenomics worth $26 as of Q2 2026.
Dunhill Financial left its NeoGenomics share count unchanged in Q2 2026.
NeoGenomics made up ﹤0.01% of Dunhill Financial's portfolio in Q2 2026, its #1578 holding.
Dunhill Financial first reported a position in NeoGenomics in Q4 2025 and has held it in 3 quarters since.
266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.